Works by Ruigrok-Ritstier, Kirsten

Results: 11
    1

    Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.

    Published in:
    Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01653-0
    By:
    • Smid, Marcel;
    • Schmidt, Marjanka K.;
    • Prager-van der Smissen, Wendy J. C.;
    • Ruigrok-Ritstier, Kirsten;
    • Schreurs, Maartje A. C.;
    • Cornelissen, Sten;
    • Garcia, Aida Marsal;
    • Broeks, Annegien;
    • Timmermans, A. Mieke;
    • Trapman-Jansen, Anita M. A. C.;
    • Collée, J. Margriet;
    • Adank, Muriel A.;
    • Hooning, Maartje J.;
    • Martens, John W. M.;
    • Hollestelle, Antoinette
    Publication type:
    Article
    2

    Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes.

    Published in:
    PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0103988
    By:
    • Beaufort, Corine M.;
    • Helmijr, Jean C. A.;
    • Piskorz, Anna M.;
    • Hoogstraat, Marlous;
    • Ruigrok-Ritstier, Kirsten;
    • Besselink, Nicolle;
    • Murtaza, Muhammed;
    • van IJcken, Wilfred F. J.;
    • Heine, Anouk A. J.;
    • Smid, Marcel;
    • Koudijs, Marco J.;
    • Brenton, James D.;
    • Berns, Els M. J. J.;
    • Helleman, Jozien
    Publication type:
    Article
    3
    4

    Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2 -Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient.

    Published in:
    Cancers, 2024, v. 16, n. 4, p. 741, doi. 10.3390/cancers16040741
    By:
    • Meijer, Titia G.;
    • Martens, John W. M.;
    • Prager-van der Smissen, Wendy J. C.;
    • Verkaik, Nicole S.;
    • Beaufort, Corine M.;
    • van Herk, Stanley;
    • Robert-Finestra, Teresa;
    • Hoogenboezem, Remco M.;
    • Ruigrok-Ritstier, Kirsten;
    • Paul, Maarten W.;
    • Gribnau, Joost;
    • Bindels, Eric M. J.;
    • Kanaar, Roland;
    • Jager, Agnes;
    • van Gent, Dik C.;
    • Hollestelle, Antoinette
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.

    Published in:
    Molecular Oncology, 2015, v. 9, n. 6, p. 1218, doi. 10.1016/j.molonc.2015.02.006
    By:
    • Jansen, Maurice P.H.M.;
    • Sas, Leen;
    • Sieuwerts, Anieta M.;
    • Van Cauwenberghe, Caroline;
    • Ramirez-Ardila, Diana;
    • Look, Maxime;
    • Ruigrok-Ritstier, Kirsten;
    • Finetti, Pascal;
    • Bertucci, François;
    • Timmermans, Mieke M.;
    • van Deurzen, Carolien H.M.;
    • Martens, John W.M.;
    • Simon, Iris;
    • Roepman, Paul;
    • Linn, Sabine C.;
    • van Dam, Peter;
    • Kok, Marleen;
    • Lardon, Filip;
    • Vermeulen, Peter B.;
    • Foekens, John A.
    Publication type:
    Article